Development
Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -718.60K | -548.20K | -417.80K | -966.30K | -432.80K |
| Total Depreciation and Amortization | 111.90K | 105.20K | 108.00K | 210.70K | 83.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 66.70K | 57.00K | 10.10K | 145.50K | 107.90K |
| Change in Net Operating Assets | 47.30K | 248.60K | 201.90K | 543.60K | 153.80K |
| Cash from Operations | -492.70K | -137.50K | -97.80K | -66.50K | -88.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.06M | 1.34M | 226.00K | 164.30K | 206.80K |
| Total Debt Repaid | -424.60K | -1.05M | -88.00K | -79.70K | -78.10K |
| Issuance of Common Stock | -- | 20.90K | -- | 6.30K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 41.10K | -- | -- | -- |
| Cash from Financing | 465.40K | 265.50K | 101.70K | 67.40K | 95.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 100.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | -- |
| Net Change in Cash | -27.30K | 128.00K | 3.80K | 900.00 | 7.60K |